Results
|
361.
|
|
|
362.
|
|
|
363.
|
|
|
364.
|
|
|
365.
|
|
|
366.
|
CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells. [electronic resource] by
- Takeshita, A
- Yamakage, N
- Shinjo, K
- Ono, T
- Hirano, I
- Nakamura, S
- Shigeno, K
- Tobita, T
- Maekawa, M
- Kiyoi, H
- Naoe, T
- Ohnishi, K
- Sugimoto, Y
- Ohno, R
Producer: 20090805
In:
Leukemia vol. 23
Availability: No items available.
|
|
367.
|
|
|
368.
|
|
|
369.
|
|
|
370.
|
|
|
371.
|
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. [electronic resource] by
- Advani, Ranjana H
- Lebovic, Daniel
- Chen, Andy
- Brunvand, Mark
- Goy, Andre
- Chang, Julie E
- Hochberg, Ephraim
- Yalamanchili, Sreeni
- Kahn, Robert
- Lu, Dan
- Agarwal, Priya
- Dere, Randall C
- Hsieh, Hsin-Ju
- Jones, Surai
- Chu, Yu-Waye
- Cheson, Bruce D
Producer: 20180209
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 23
Availability: No items available.
|
|
372.
|
Identification of Siglec Ligands Using a Proximity Labeling Method. [electronic resource] by
- Chang, Lanyi
- Chen, Yi-Ju
- Fan, Chan-Yo
- Tang, Chin-Ju
- Chen, Yi-Hsiu
- Low, Penk-Yeir
- Ventura, Albert
- Lin, Chun-Cheng
- Chen, Yu-Ju
- Angata, Takashi
Producer: 20180522
In:
Journal of proteome research vol. 16
Availability: No items available.
|
|
373.
|
|
|
374.
|
|
|
375.
|
|
|
376.
|
|
|
377.
|
|
|
378.
|
|
|
379.
|
|
|
380.
|
|